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ABSTRACT  
Reproducible control of stoichiometry and difficulties in large scale production have been 
identified as two of the major challenges to commercial uptake of pharmaceutical co-crystals. 
The aim of this research was to extend the application of SFCC to control stoichiometry in 
caffeine: maleic acid co-crystals. Both 1:1 and 2:1 caffeine: maleic acid co-crystals were 
produced by control of the feedstock composition and process conditions. It was also 
observed that formation of 2:1 stoichiometry co-crystals involved formation of a 1:1 co-
crystal which was subsequently transformed to 2:1 co-crystals. The investigation of 
stoichiometric transformation revealed that although 1:1 co-crystals could be converted into 
2:1 form with addition of excess caffeine, the reverse was not possible in the presence of 
excess maleic acid. However, conversion from 2:1 into 1:1 was only achieved by melt 
seeding with the phase pure 1:1 co-crystals. This investigation demonstrates that 
stoichiometric control can be achieved by SFCC by control of parameters such as extrusion 
temperature. 
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Co-crystallization is one of the approaches used in the pharmaceutical industry to improve 
physicochemical properties such as solubility, bioavailability and stability of active 
pharmaceutical ingredients (APIs)1. The importance of co-crystals has been reflected by the 
recent guidelines issued by regulatory agencies for industry concerning the use of cocrystals2. 
Co-crystals existing in different stoichiometries can provide a means to increase the number 
of potential solid forms for a given molecule, however they can also complicatecontrol of the 
co-crystallization process and subsequent interconversion. Many research groups are 
exploring innovative co-crystallisation techniques for stoichiometric control and phase pure 
co-crystal synthesis3,4. Karki et al. reported that grinding can be used to control the formation 
of stoichiometrically diverse co-crystals by altering the ratio of the reactant mixture5. 
Recently, our group reported SFCC technology based on the application of melt extrusion for 
the manufacture of cocrystals6,7,8. During this process the drug – co-former mixture is 
subjected to shear and heating while being conveyed along the barrel length. Extrusion is an 
effective process for mixing whilst maintaining the stoiciometric ratio of the feed components 
along its length. 
The aim of this study was to explore the application of SFCC to control stoichiometry during 
co-crystallization using caffeine:maleic acid (caf:ma) as a model system. Caffeine is a 
challenging pharmaceutical compound which exhibits two anhydrous polymorphic forms, 
one crystalline non-stoichiometric hydrate and one salt phase9. Its weak basicity and the 
possibility of forming heteromeric synthons makes it suitable for co-crystallization. Caffeine 
shows stoichiometric diversity with maleic acid, forming either 1:1 or 2:1 caf:ma co-crystals. 
Existence of co-crystals in different stoichiometries increases the number of potential solid 
forms for a given molecule but complicates control of the co-crystallisation process and 
subsequent inter-conversion. Various co-crystallization techniques used to obtain caf:ma co-
crystals with 1:1 and 2:1 stoichiometries are summarised in Table 1. 
 
Table 1. Summary of caffeine: maleic acid co-crystallisation studies 
 
Trask et al. were the first to perform a thorough crystal engineering study of caffeine with 
maleic acid using neat and liquid assisted grinding (LAG) methods. This study suggested that 
1:1 or 2:1 caf:ma co-crystals could be prepared depending on the choice of solvent10. 
Methanol favours formation of 2:1 whereas toluene favours 1:1 co-crystals. Guo et al. further 
explored the same system using dry grinding, LAG and solution co-crystallization11. The 
authors were successful in obtaining 1:1 and 2:1 co-crystals by LAG using acetone for both 
stoichiometries. Due to the non-congruent solubility behaviour of the two components, an 
excess of maleic acid (1:7 molar ratio) was required to obtain 1:1 co-crystals in solution 
crystallisation. Aher et al. reported ultrasound assisted solution co-crystallization (USCC) in 
methanol to yield pure 2:1 caf:ma co-crystals12. However, a significant excess of maleic acid 
(1:3.5 molar ratio) was required to achieve this. Leyssens et al. noted the importance of 
solvent selection during crystallisation of stoichiometrically diverse co-crystal synthesis 
andshowed that formation of caf:ma 2:1 co-crystals occurs at high levels of supersaturation9. 
Pagire et al. generated almost phase pure 1:1 and 2:1 caf:ma co-crystals using microwave 
radiation13. 
Furthermore, it was demonstrated that methanol favours formation of form II of 1:1 caf:ma 
co-crystals in the presence of microwaves. Recently, our group constructed a phase diagram 
for caf:ma co-crystals and studied the effect of ultrasound on it14. It was observed that 1:1 
and 2:1 regions are very narrow, suggesting that it is difficult to obtain phase pure 1:1 and 2:1 
co-crystals. Overall, it appeared that solvent selection and kinetics play an important role in 
formation of caf:ma co-crystals. Guo et al. reported that the 2:1 co-crystal is an unstable 
phase compared to the 1:1 stoichiometry at room temperature11. Therefore, it is challenging 
to obtain phase pure 1:1 and 2:1 caf:ma co-crystals, hence the current exploration of 
controlled stoichiometry by SFCC. 
Preliminary screening experiments using DSC (TA instruments Q2000 DSC with RCS90 
cooling unit) were performed in order to study caf:ma eutectic formation. DSC endotherms 
are provided in the supporting information. Caffeine showed two endothermic peaks at 156°C 
and 236°C15. Maleic acid exhibited a single endothermic melting peak at 143°C followed by 
degradation at higher temperature indicated by an out of shape recovery of the endothermic 
peak. DSC thermograms from the physical mixture in 1:1 ratio showed a first endothermic 
peak at 100°C, significantly lower than the melting point of the either component which may 
be due to eutectic formation16. This was followed by a further endothermic peak at 104°C 
which may be attributed to the melting of 1:1 co-crystal formed during DSC. The physical 
mixture in 2:1 ratio showed multiple endothermic peaks at 97, 100 and 104°C; again lower 
than the melting point of either component. The peaks at 97 and 100°C may be due to the 
eutectic formation in different ratios and the peak at 104°C might be due to the melting of 1:1 
co-crystal formed during heating past the eutectic temperature16. These peaks were followed 
by uneven events similar to those with the 1:1 ratio except that an additional peak was 
observed at 235°C which was attributed to melting of unutilised caffeine in the mixture. 
Based on the results of thermal analyses, caf:ma acid co-crystallisation experiments were 
conducted in a twin screw extruder (Pharmalab, ThermoScientific, UK with screw diameter 
16 mm and length to diameter ratio 40 : 1) at set temperatures below and above the eutectic 
temperature at a screw speed of 10 rpm. The screws were configured to produce high shear 
intensity (described as Configuration C in our previous reports6,7,8). The 1:1 co-crystal 
batches were processed at set temperatures of T80, T90 and T100, while 2:1 co-crystal 
batches were processed at set temperatures of T100, T105 and T110; full details of each set 
temperatures are provided in the supporting information. Powder X-Ray Diffraction (PXRD) 
measurements made using a Bruker D8 diffractometer (wavelength of X-rays 0.154 nm Cu 
source, voltage 40 kV, and filament emission 40 mA) were used to characterize the 
crystalline components. 
Caf:ma batches processed below the eutectic point did not show significant co-crystal 
formation in either 1:1 or 2:1 ratios. The 1:1 mixture was processed at T100 (above the 
eutectic temperature) resulted in improved conversion levels of (1:1) co-crystals. When a 2:1 
mixture was processed at T100 (above the eutectic temperature) peaks corresponding to 2:1 
co-crystal (2θ = 9, 11.1, 14.2 and 15.5) and unreacted caffeine (2θ=12) along with traces of 
1:1 co-crystal (2θ = 11.1, 13.2, 14.2 and 15.5) were observed. However, processing the same 
2:1 mixture at an increased temperature of T110 led to formation of phase pure 2:1 co-
crystals. Therefore, all the further co-crystallisation experiments for 2:1 mixture were 
conducted at T110. Figure 1 shows PXRD patterns of caf:ma physical mixture 1:1, caf:ma 
co-crystals 1:1, caf:ma physical mixture 2:1 and caf:ma co-crystals 2:1. Caf:ma 1:1 co-
crystals showed an endothermic peak at 104°C whereas caf:ma 2:1 co-crystals exhibited an 
endothermic peak at 118°C as reported by Guo et al11. 
The issue of stoichiometric control in co-crystals which exists in multiple stoichiometries has 
been extensively studied recently and the complexity of controlling the purity and 
interconversion has been discussed. Karki et al. compared the co-crystallisation of 
nicotinamide with 10 dicarboxylic acids from solution, melt and by neat and liquid assisted 
grinding5. These screening experiments suggested that co-crystallisation did not result in the 
co-crystal composition corresponding to the stoichiometry of the starting material in 50% of 
cases from solution, 40% of cases from melt and in 25% of cases from neat and liquid 
assisted grinding. In most cases both stoichiometries could not be obtained using the same 
technique. Here, SFCC was successfully used to obtain phase pure co-crystals of caf:ma in 
both stoichiometries, through control of composition of the reaction mixture and process 
temperature. Interestingly a higher processing temperature (T110) was required to obtain 2:1 
co-crystals compared to 1:1 co-crystals (T100) even though the eutectic temperatures were 
noted in a similar range for both ratios. 
 
 Figure 1. PXRD patterns of (a) caffeine, (b) maleic acid, (c) caffeine: maleic acid physical 
mixture 1:1, (d) caffeine: maleic acid co-crystals 1:1, (e) caffeine: maleic acid physical mixture 
2:1 and (f) caffeine: maleic acid co-crystals 2:1.  
 
As discussed above, extrusion of the 2:1 mixture at T100 resulted in formation of a mixture 
of 2:1 and 1:1 co-crystals along with caffeine. In order to investigate this further the 2:1 
mixture was also extruded at set temperatures of T105 and T110. These experiments showed 
that at T105 PXRD peaks corresponding to 2:1 co-crystals increased as peaks corresponding 
to 1:1 co-crystals and caffeine decreased. At temperature set of T110 complete 
transformation to 2:1 co-crystal was obtained. This indicates that processing a 2:1 mixture 
lead to formation of a 1:1 co-crystal which was subsequently transformed to 2:1 co-crystal. 
Formation of 1:1 co-crystal was favoured when a 2:1 mixture was processed below 104°C, 
this co-crystal form is stable up to 104°C. As the temperature exceeds 104°C, the 1:1 co-
crystal melts and the components are free to form the thermodynamically more stable 2:1 co-
crystal. This explains why formation of phase pure 2:1 co-crystals was obtained only after 
processing at T110. Karki et al. also observed formation of 1:1 co-crystals of nicotinamide 
and suberic acid as an intermediate synthesis during co-crystallisation of 2:1 co-crystal by 
LAG5.  
In order to confirm these observations and understand the process of co-crystal formation, a 
separate experiment was conducted at T110 using the physical mixture in 2:1 ratio. The 
extrusion process was stopped abruptly and samples were collected at several points along 
the length of the extruder screw and examined using PXRD. The resulting diffractograms 
(included in the supporting information) indicated a mixture of a 2:1 blend and 1:1 co-
crystals close to the extruder feed section with a gradually increasing proportion of 2:1 co-
crystals along the barrel and phase pure 2:1 co-crystals in the terminal zones of the extruder. 
These results provided further evidence that the formation of 2:1 co-crystal occurred in a 
stepwise mode, wherein the caf:ma 1:1 co-crystals appeared first then successively converted 
to 2:1 stoichiometry. 
Boldyreve et al. reported polymorphic transformation of paracetamol is dependent on the 
increasing and decreasing pressure17. Therefore, in an attempt to assess the stability of co-
crystals produced by SFCC, both stoichiometries were re-extruded at temperature profiles 
T100 and T110, and the products examined by PXRD. Results indicated that no change in co-
crystal stoichiometry or purity occurred during re-processing, suggesting that both caf:ma 
1:1 and 2:1 co-crystals were stable at high intensity shear conditions. 
An investigation of inter-conversion of stoichiometric form was also performed. Caf:ma 1:1 
co-crystals obtained by SFCC were mixed with caffeine in an amount equivalent to produce a 
2:1 stoichiometry and then extruded. The blend was extruded at different temperature profiles 
(T90, T100 and T110). Results of subsequent PXRD analyses are provided in the supporting 
data. Extrusion at T90 showed prominent PXRD peaks at 2θ=12 corresponding to excess 
caffeine along with retention of the peaks corresponding to 1:1 co-crystals. However, 
processing at T100 showed a significant reduction in peaks corresponding to co-crystal 1:1 
and caffeine with a proportional increase in the intensities of the peaks corresponding to co-
crystal 2:1. At T110 complete conversion into 2:1 co-crystals was observed. These 
experiments confirmed the initial observation that formation of 2:1 co-crystals involves 
formation of 1:1 co-crystals and that SFCC is capable of converting 1:1 stoichiometry into 
2:1. 
In a similar manner, experiments were conducted on a mixture of 2:1 co-crystals obtained by 
SFCC, fed into the extruder with excess maleic acid to give a 1:1 molar composition. As 1:1 
co-crystals are known to melt at 105°C, an experiment was performed at an extrusion 
temperature of T120 in addition to T100 and T110. In each of these experiments, no material 
changes were observed; 2:1 co-crystals along with excess maleic acid were produced as 
confirmed by PXRD peaks corresponding to 2:1 co-crystals and a peak at 2θ =28, 
corresponding to maleic acid. At T100 and T110 the 2:1 co-crystal does not melt and hence 
the components are not free for conversion into 1:1 co-crystal. At 120°C (T120) 2:1co-
crystals melt and the components are available for conversion into 1:1 co-crystals by utilising 
the excess maleic acid. However, this conversion was not observed. This observation 
indicated that at higher processing temperatures 2:1 appeared to be the favoured 
stoichiometry. 
During solution crystallization, relative stability of caf:ma co-crystals is dependent on 
various factors such as solubility, solvation and nucleation processes. But these factors were 
found to be greatly reduced during grinding experiments providing more reliable conclusions 
on the relative stabilities of co-crystals than in solution crystallization5. The solvents used in 
LAG are also reported to favour the formation of particular co-crystal stoichiometries and 
hence have some degree of influence over the process10. However, SFCC experiments are 
completely solvent free and hence independent of the solvent effects and thus can provide 
valuable insight into the relative stabilities of co-crystals. It was observed during the 
interconversion experiments that caf:ma 1:1 co-crystals are formed as an intermediate during 
formation of caf:ma 2:1. Therefore, 1:1 co-crystal stoichiometry could be converted into 
caf:ma 2:1, whereas the reverse conversion was not possible. These results indicate that the 
2:1 stoichiometry obtained from solvent free method is the more stable form of this co-
crystal. 
 
Figure 2. Schematic representation of caffeine: maleic acid co-crystal formation using SFCC 
In further experiments, an attempt was made to obtain caf:ma 1:1 co-crystals from caf:ma 
2:1 co-crystals by melt seeding. Caf:ma 1:1 co-crystals were mixed with an excess amount 
of maleic acid. Extrusion was performed at T100, T110 and T120 and 15% caf:ma 1:1 co-
crystals were added at zone 6 as a seed. Interestingly, all experiments resulted in complete 
conversion into caf:ma 1:1 co-crystals. A schematic representation of this process is shown 
in figure 2. Similar observations were reported by Orban et al. by seeding a melt of 
pentaerythritoltetrakis- [3-(3, 5-di-tert-butyl-4- hydroxyphenyl) propionate] with a small 
amount of the crystalline compound18. This seeding melt approach can be useful in achieving 
complete conversion to the co-crystals at lower processing temperatures and shear intensities 
than otherwise required. 
 
CONCLUSION 
 
The application of SFCC has been successfully demonstrated to control stoichiometry of 
caf:ma co-crystals. This solvent-free, high temperature process is capable of yielding phase 
pure 2:1 caf:ma co-crystals. The prepared pure co-crystals were found to be stable during re-
extrusion. Conversion of 1:1 co-crystals into 2:1 stoichiometry was readily achieved by 
SFCC but conversion from 2:1 into 1:1 was only achieved by seeding with the phase pure 1:1 
co-crystals. The melt seeding approach is proposed as a useful method to achieve pure co-
crystals at low processing temperature and shear intensity. 
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SUPPORTING INFORMATION 
 
Figure1. PXRD patterns of 2:1 co-crystals from 1:1 caffeine: maleic acid co-crystals processed at 
different temperature profiles (a) 1:1 co-crystals with maleic acid processed at T110, (b) 1:1 co-
crystals with maleic acid processed at T100, (c) 1:1 co-crystals with maleic acid processed at T190 
and (d) Pure 1:1 caffeine; maleic acid co-crystals  
 Figure2. PXRD patterns of 2:1 co-crystals with from 1:1 caffeine: maleic acid co-crystals processed at 
different temperature profiles (a) 2:1 co-crystals with maleic acid processed at T100, (b) 2:1 co-
crystals with maleic acid processed at T110, (c) 2:1 co-crystals with maleic acid processed at T120 
and (d) Pure 2:1 caffeine: maleic acid co-crystals 
 Figure 3. PXRD patterns of sample collected from different zone during extrusion of 1:1 co-crystals 
(a) sample collected from zones 2-4, (b) sample collected from zones 4-6, (c) sample collected from 
zones 6-8 and (d) samples collected from zones 8-10 
 
 Figure 4. PXRD patterns of sample collected from different zone during extrusion of 2:1 co-crystals 
(a) samples collected from zones 2-4, (b) samples collected from zones 4-6, (c) samples collected 
from zones 6-8 and (d) samples collected from zones 8-10 
 
 Figure 5.DSC thermograms for (a) maleic acid, (b) anhydrous β-caffeine, (c) physical mixture (1:1), 
and (d) physical mixture (2:1), (e) caffeine/maleic acid 1:1 co-crystals and (f) caffeine/maleic acid 2:1 
co-crystals 
Table 1.Temperature profiles across the different zones of the extruder barrel 
 
 
 
 
 
Code Zone 10 Zone 9 Zone 8 Zone 7 Zone 6 Zone 5 Zone 4 Zone 3 Zone 2 
T90 50 70 90 80 70 55 40 35 25 
T100 50 80 100 90 80 55 40 35 25 
T105 50 90 105 100 80 55 40 35 25 
T110 60 100 110 100 80 60 40 35 25 
T120 90 110 120 110 100 90 75 35 25 
Table 2: Co-crystallisation experimental detail showing resultant products 
Batch 
code 
Gram/batch Temp. 
Coding 
Screw 
Speed  
Product 
(major + minor) Caffeine  Maleic acid 
Caf:Mal 
(1:1) 
194 116 
T100 10 CC 
T90 10 CC + Caffeine 
T80 10 Caffeine + CC 
Caf:Mal 
(2:1) 
388 116 
T110 10 CC  
T105 10 CC + Caffeine 
T100 10 Caffeine + CC 
 
 
 
 
 
 
 
 
 
